| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2006 | US20060100131 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 05/11/2006 | US20060099693 High-quality lipids and methods for producing by enzymatic liberation from biomass |
| 05/11/2006 | US20060099691 Production of complex carbohydrates |
| 05/11/2006 | US20060099690 Extraction, purification and conversion of flavonoids from plant biomass |
| 05/11/2006 | US20060099671 Methods and compositions for generating angiostatin |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099586 Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer |
| 05/11/2006 | US20060099568 Signals and molecular species involved in senescence |
| 05/11/2006 | US20060099324 Composition comprising viscous fibers and viscosity-lowering proteins |
| 05/11/2006 | US20060099321 Cereal based food product comprising dha and/or epa |
| 05/11/2006 | US20060099283 Leaf juice of plectranthus amboinicus for treating cancer and/or tumor |
| 05/11/2006 | US20060099278 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099275 Cell permeable peptides; inhibit NF-kB activation; inhibit anti-apoptotic processes in cancer cells to promote tumor cell death |
| 05/11/2006 | US20060099271 Contacting microparticles og biodegradable, biocompatible polymer matrix comprising a peptide with halogenated solvent with nonaqueous washing system |
| 05/11/2006 | US20060099269 Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
| 05/11/2006 | US20060099267 High-dosage extended-release formulation of gepirone |
| 05/11/2006 | US20060099266 Slow release formulation of clarithromycin |
| 05/11/2006 | US20060099265 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 05/11/2006 | US20060099263 Antidepressant dosage form |
| 05/11/2006 | US20060099259 Propranolol formulations |
| 05/11/2006 | US20060099258 Propranolol formulations |
| 05/11/2006 | US20060099257 Controlled drug delivery systems providing variable release rates |
| 05/11/2006 | US20060099255 solid dosage forms for oral administration, reducing the range in daily dosages required to control pain in human patients |
| 05/11/2006 | US20060099254 Sustained release drug delivery system and method |
| 05/11/2006 | US20060099253 Antibiotic product formulation |
| 05/11/2006 | US20060099252 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 05/11/2006 | US20060099251 Formulations of finasteride |
| 05/11/2006 | US20060099250 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets |
| 05/11/2006 | US20060099248 5,6,7-Trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 05/11/2006 | US20060099245 Hydrodynamically balancing oral drug delivery system with biphasic release |
| 05/11/2006 | US20060099244 Liposomal formulation for oral administration of glutathione (reduced) |
| 05/11/2006 | US20060099240 eating candy comprising homogeneous mixtures of guaran and derivatives, hydroxycitric acid, tyrosine, Vitamin B6, Vitamin B12, cyanocobalamin, corn syrup and maltodextrin and derivatives, as anorexigenic agents |
| 05/11/2006 | US20060099239 Dietary supplement for promoting removal of heavy metals from the body |
| 05/11/2006 | US20060099237 Antimicrobial medical articles containing a combination of anti-infective compounds, octoxyglycerin, salicylic acid, and sesquiterpenoids |
| 05/11/2006 | US20060099236 comprising a saponin composition including a triterpene or other aromatic terpenoid composition; growth-inhibiting properties and/or anti-inflammatory properties; stent comprising the avicin reduces at least in part restenosis, such as that associated with stent procedures |
| 05/11/2006 | US20060099230 Novel formulations of eprosartan with enhanced bioavailability |
| 05/11/2006 | US20060099227 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyethyl Starch |
| 05/11/2006 | US20060099222 Novel mixture and compounds from mycelia of antrodia camphorata and use thereof |
| 05/11/2006 | US20060099217 Inhibiting MHC class I antigen processing by ER aminopeptidase by administering an aminopeptidase inhibitor that is leucine-thiol, lysine-thiol, isoleucine-thiol, bis(1-thio-2-amino-4-methylpentane) diHCL, bis(1-thio-2-amino-3-phenylpropane) diHCL, or an alpha-thiolbestatin and confirming inhibition |
| 05/11/2006 | US20060099212 treating or preventing a tumor necrosis factor-mediated disease by co-administering methotrexate and a TNF alpha antagonist |
| 05/11/2006 | US20060099208 Method of potentiating the therapeutic action of monoclonal and polyclonal antibodies |
| 05/11/2006 | US20060099197 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/11/2006 | US20060099188 Tumor-specific promoter |
| 05/11/2006 | US20060099173 Topical skin care composition |
| 05/11/2006 | US20060099172 Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of prophylaxis and treatment of avian influenza |
| 05/11/2006 | US20060099170 Compositions for inducing increased levels of beta-chemokines and methods of use therefor |
| 05/11/2006 | US20060099169 Toxin binding compositions |
| 05/11/2006 | US20060099158 Preparation containing conjugated linoleic alcohol |
| 05/11/2006 | US20060096587 Comestibles containing isomaltulose and trehalose for sustained carbohydrate energy release and reduced glycemic/insulinemic responses, and for preserving osmolality |
| 05/11/2006 | US20060096522 Apparatus and process for preparing crystalline particles |
| 05/11/2006 | DE3943807B4 Prepn. for iron supply - comprises specified amts. of specified iron contg. cpd., sodium carbonate or bi:carbonate and a neutralising agent |
| 05/11/2006 | DE202006004172U1 Mittel zur Bekämpfung von Ectoparasiten und deren Eiern Agents for combating ectoparasites and their eggs |
| 05/11/2006 | DE19802539B4 Verwendung von Diethylentriamin-Pentaessigsäure zum Herstellen einer Schutzcreme gegen Kontaktdermatitis Using diethylenetriamine pentaacetic acid for producing a protective cream against contact dermatitis |
| 05/11/2006 | DE10356925B4 Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung An inhaler for basic pharmaceutical agents, and methods for its preparation |
| 05/11/2006 | DE102004054730A1 Serumstabile amphotere Liposomen Serum-stable amphoteric liposomes |
| 05/11/2006 | DE102004054426A1 Use of phosphatidyl choline and/or other lipids for preparing medicaments for treating inflammatory small and/or large intestine diseases e.g. colitis ulcerosa, and for the prophylaxis of colon cancer |
| 05/11/2006 | DE102004054216A1 Substituierte 4-Amino-pyridopyrimidinone Substituted 4-amino-pyridopyrimidinone |
| 05/11/2006 | DE102004054215A1 Pyridopyrimidinonderivate Pyridopyrimidinonderivate |
| 05/11/2006 | DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | DE102004054040A1 Wirkstoffhaltige Silikonelastomere Active ingredient-containing silicone elastomers |
| 05/11/2006 | CA2762076A1 Aliphatic amine polymer salts for tableting |
| 05/11/2006 | CA2590981A1 Multiple layer coating composition |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2589106A1 Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases |
| 05/11/2006 | CA2589102A1 Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| 05/11/2006 | CA2588278A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2587489A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | CA2587481A1 Phenylalkylamino carbamates adjunctive therapy for depression |
| 05/11/2006 | CA2586938A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 05/11/2006 | CA2586845A1 Therapeutic treatment of accelerated bone resorption |
| 05/11/2006 | CA2586821A1 Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
| 05/11/2006 | CA2586602A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | CA2586277A1 Novel pharmaceutical compositions and the uses thereof for controlling the different forms of addiction to drugs |
| 05/11/2006 | CA2586271A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2586259A1 Novel fused imidazole derivative |
| 05/11/2006 | CA2586254A1 Therapeutic agent for neuropathic pain |
| 05/11/2006 | CA2586212A1 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis |
| 05/11/2006 | CA2586177A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | CA2586174A1 Methods of preparing indazole compounds |
| 05/11/2006 | CA2586073A1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/11/2006 | CA2586066A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | CA2586039A1 Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| 05/11/2006 | CA2586021A1 Once a day formulation for phosphate binders |
| 05/11/2006 | CA2585967A1 Substituted indolizines and derivatives as cns agents |
| 05/11/2006 | CA2585934A1 Novel pyrazolopyridine urea kinase inhibitors |
| 05/11/2006 | CA2585925A1 Tetrahydro-pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | CA2585866A1 Stable aqueous formulation of a platin derivative |
| 05/11/2006 | CA2585855A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 05/11/2006 | CA2585852A1 Dye-free pharmaceutical suspensions and related methods |
| 05/11/2006 | CA2585841A1 Method of reducing nosocomial infections |
| 05/11/2006 | CA2585840A1 Use of an mtor inhibitor in treatment of uterine leiomyoma |
| 05/11/2006 | CA2585754A1 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy |
| 05/11/2006 | CA2585735A1 Novel compounds of substituted and unsubstituted adamantyl amides |
| 05/11/2006 | CA2585666A1 Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
| 05/11/2006 | CA2585658A1 Estrogen receptor modulators |
| 05/11/2006 | CA2585647A1 Dose forms comprising vx-950 and their dosage regimen |
| 05/11/2006 | CA2585621A1 Improved quenching methods for red blood cell inactivation process |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |